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ABSTRACT
Background: Hyperbaric Oxygen Therapy (HBOT) is a method of 
increasing oxygen delivery to tissues. The therapy improves tissue 
oxygenation and stimulates the formation of H
2
O
2
 as a secondary 
messenger for tumor necrosis factor alpha (TNFα), interferon gamma 
(IFNγ) and nuclear factor kappa beta phosphorylation (NF-kB) which 
play an important role in the rapid transcription of a wide variety of 
genes in response to extracellular stimuli. 
Aim: This study aims to determine the effects of Hyperbaric Oxygen 
therapy in enhancing the expressions of IFNγ and TNFα in pregnant rats 
infected with Toxoplasma gondii. 
Methods: This study is an animal study with a ‘randomized control 
group of post-test only design’ on 34 Rattus novergicus Sprague 
Dawley rats. Randomly, the rats were divided into four groups. The 
HBOT treatment group A is pregnant rats infected with tachyzoite 
received 10 sessions of HBOT 2.4 ATA in 3x30 minutes. B is Pregnant 
only and received 10 sessions of HBOT 2.4 ATA in 3x30 minutes. C is 
pregnant and infected with tachyzoite but not received HBOT. And 
the last, D is pregnant rats only without infection and not received 
HBOT. Each infected pregnant rats were given a 103 Tachyzoite of 
Toxoplasma gondii via intraperitoneal injection. Examinations of IFNγ 
and TNFα expressions were performed on day-5 after HBOT (HBOT 
twice a day). Rats that die or experience abortion will be eliminated 
while rats that still survive will be taken the blood by intracardiac 
technique. IFNγ and TNFα levels were measured by serum ELISA 
examination. 
Results: The results showed that the HBOT could improve IFNγ 
(p=0.000), TNF-α (p= 0.02) significantly in the provision of HBOT 2.4 
ATA for 3x30 minutes in 10 sessions over five days of therapy. 
Conclusion: HBOT can improve the expressions of IFNγ and TNFα, in 
the provision of HBOT 2.4 ATA for 3x30 minutes, 10 times in 5 days and 
HBOT administration can prevent abortion in pregnant rats infected 
with tachyzoite T. gondii.
Keywords: Toxoplasma gondii, Tachyzoite, Hyperbaric Oxygen Therapy, IFNγ, TNFα
Cite this Article: Nurdianto, A.R., Aryati, Suryokusumo, M.G., Mufasirin. 2019. Effect of hyperbaric oxygen therapy to IFNγ and TNFα expression in 
pregnant Rattus novergicus infected with Tachyzoite of Toxoplasma gondii. Bali Medical Journal 8(1): 94-100. DOI:10.15562/bmj.v8i1.1316
Effect of hyperbaric oxygen therapy to IFNγ and 
TNFα expression in pregnant Rattus novergicus 
infected with Tachyzoite of Toxoplasma gondii
Arif Rahman Nurdianto,1* Aryati,2 Mohammad Guritno Suryokusumo,3 Mufasirin4
INTRODUCTION
IFNγ is an interleukin that plays a major role in 
the abortion of pregnant women infected with 
Toxoplasma gondii. The majority of abortions within 
the positive group for T. gondii fall in 12 weeks (41%) 
followed by 8 (15%) and 10 (12%) weeks of gesta-
tional age.1 Cell-mediated immune responses are 
essential for against toxoplasmosis.2 Resistance to 
T. gondii is mainly mediated by type 1 cytokines, such 
as IFNγ which is central in resistance to T.  gondii 
infection, whereas type 2 cytokines, such as IL4 and 
IL10, are associated with increased susceptibility 
to infection.3,4 Susceptibility of the pregnant host 
to toxoplasmosis may be due to a type 2 cytokine 
bias that is maintained during gestation.5 T. gondii 
is a potential stimulus of type 1 cytokines, perhaps 
reflecting in keeping the host alive during infection. 
On the other hand, there is the likelihood that strong 
type 1 response induced early during T. gondii infec-
tion will induce abortion early in pregnancy.6,7 
A type 2 cytokine bias has been identified in 
normal murine placenta and is associated with 
successful implantation maintenance of early 
pregnancy, and suppression of local inflammatory 
responses.8 On the other hand, type 1 cytokines 
cause inflammatory immune reactions and graft 
rejection mechanisms which lead to the abortion of 
the conceptus.9
Cytokine TNFα is released by macrophages 
when the body is infected with T. gondii that serves 
to eliminate parasites. In addition, the cytokine 
also affects other cells that are not infected and 
cause apoptosis.10 At the onset of infection, IFNγ is 
produced by natural killer cells (NK). In this phase 
involves the innate immune system, NK cells and 
macrophages. NK cells are the main cells produc-
ing IFNγ and will activate macrophages to produce 
TNFα as microbicides. In the chronic phase, 
T lymphocytes produce IFNγ in large quantities.11
HBOT may suppress the inflammatory process 
shown in some studies.12-15 In healthy humans 
treated with OHB with a dose of 2.8-3 ATA for 
45 minutes, the ability of neutrophils in the blood 
circulation to attach to his target tissue will be 
temporarily impeded.16 Administrated HBOT 
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(2 ATA for 60 minutes) at 12 hours after injury 
reduced the RNA and protein levels of caspase-3, 
interleukin- 8 and tumor necrosis factor-α.14 HBOT 
improved outcomes and reduced inflammation 
by increasing anti-inflammatory cytokine inter-
leukin-10,13,17 and decreasing the level of TNFα.18 
Recently, HBOT significantly increased the expres-
sion of heme oxygenase-1, and inhibited the expres-
sion of NF-kB in a rat TBI model.15,19 
Mechanism of HBOT in Pregnant Rats needs to 
be proven. This study tried to find the influence of 
HBOT on serum levels IFNγ and TNFα in pregnant 
rats infected with tachyzoite Toxoplasma gondii. 
The results of this study are expected to explain the 
mechanism of administration of HBOT in pregnant 
rats with toxoplasmosis.
MATERIAL AND METHODS
This study is an animal study with a ‘random-
ized control group of post-test only design’ on 34 
Sprague Dawley rats. Randomly, the rats were 
divided into four groups with nine rats in each 
group. The HBOT treatment group A is pregnant 
rats infected with tachyzoite received ten sessions of 
HBOT 2.4 ATA in 3x30 minutes. B is Pregnant only 
and received ten sessions of HBOT 2.4 ATA in 3x30 
minutes. C is pregnant and infected with tachyzoite 
but not received HBOT. And the last, D is preg-
nant rats only without infection and not received 
HBOT. Each infected pregnant rats were given a 
103 Tachyzoite of Toxoplasma gondii via intraperi-
toneal injection. Examinations of IFNγ and TNFα 
expressions were performed on day-5 after HBOT 
(HBOT twice a day). Euthanized or aborted rats 
will be eliminated while rats that still survive will be 
taken intracardiac blood by intracardiac technique. 
IFNγ and TNFα levels were measured by serum 
ELISA examination.
RESULTS
IFNγ data from 4 groups of research conducted 
homogeneity test obtained significance value of 
(0.194) which shows the data is homogeneous. 
Then the results of One Way ANOVA test showed 
a significant value of (0.000) with significant value 
when p <0.05. Then the above data was tested again 
with Pearson correlation test and obtained signifi-
cance result of p = 0.041 indicating that there is a 
relationship between IFNγ level with TNFα levels 
in the treatment of HBOT in pregnant rats infected 
with Tachyzoite infection.
There was a significant correlation between 
HBOT at IFNγ and TNFα concentrations in preg-
nant rats infected with T. gondii tachyzoite between 
and within group A, B, C, D. The administration 
of HBOT can have a significant effect on the elim-
ination of tachyzoite infection in pregnant rats as 
indicated by p <0.000.
DISCUSSION
T. gondii infected macrophages produce IL12 which 
activates NK cells to produce IFNγ and stimulates 
the differentiation of T helper (Th) lymphocytes 
into Th1 cells. Th1 cells produce IFNγ and IL2. 
Macrophages as Antigen Presenting Cell (APC) 
express Major Histocompatibility Complex I 
(MHC I) so that it was captured by T cell receptors 
(Cytotoxic T Leucocyte, CTL). The resulting cyto-
kine IL2 induces CTL to produce IFNγ. IFNγ is 
essential for macrophage activation and to promote 
macrophage function as microbicides.10 As the 
results of the study of cytokines in groups C and 
A, the significant increment of IFNγ were found 
chiefly in group A.
Increased dissemination of transplacental 
tachyzoite is associated with increased IFNγ secre-
tion.20,21 Increased IFNγ secretion is related to 
increased ICAM1 molecules that facilitate mono-
cyte migration.21,22 On the other hand, monocytes 
are permissive and dominant cells infected by 
takizoit23 and facilitate tachyzoite migration to 
the placenta. Although monocytes will not enter 
the fetal circulation, it can actively penetrate the 
placental tissue with its gliding movements and 
transmigration capabilities.24 Thus, T. gondii has a 
greater chance of spreading and invading placental 
tissue associated with an increase in inflammatory 
cytokines in acute cases. In chronic cases, IFNγ 
is neutralized to cause fetomaternal tachyzoite 
transmission through the placenta.25 Based on the 
above research, IFNγ has a vital role in the process 
of elimination of T. gondii in the body in optimum 
concentration as IFNγ has a destructive effect and 
vice versa at low concentrations can also decrease 
the elimination activity of T. gondii. The results of 
this study showed that there were no rats that had 
an abortion with the administration of tachyzoite 
infection with a dose of 103 via intraperitoneal in 
groups A and C, although there was a much higher 
concentration of IFNγ compared to the control 
group (groups B and D). This can be achieved by 
giving HBOT while can increase IFNγ without 
causing abortion.
As from the Figure 1, we know if group A had 
a higher concentration of IFNγ better than group 
C, D, and B. This showed that HBOT administra-
tion in this study in groups A and C could increase 
the IFNγ which had a vital role in the elimination 
process of T. gondii. As against in group B and D, 
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IFNγ is still in a lower level because the group did 
not experience T. gondii infection, although in a 
study by Suwanti (2005) which stated that in the 
first trimester the immunohistochemistry picture 
shows an increase in the number of IFNγ because 
the large IFNγ production in the embryo implanta-
tion process.26
T. gondii evokes a strong cellular immune 
response toward T helper-1 (Th1) T cells charac-
terized by the creation of Th1 cytokines such as 
IFNγ and interleukin-2 (IL2).10 Increased IFNγ 
as the induced response of cytokine Th1 to the 
fetal-maternal interface caused fetal rejection. IFNγ 
is produced by NK cells and CD8+ T cells. There 
were three alternative pathways of IFNγ synthesis 
as the host’s response to T. gondii infection.27 This 
was consistent with the results shown by this study 
where IFNγ in groups A and C was higher than in 
groups C and D.
T.gondii-infected macrophages produced IL12 
which activated NK cells to produce IFNγ and 
T helper (Th) differentiation into Th1 cells that 
produce IFNγ and IL2. Macrophages expressed 
Major Histocompatibility Complex I (MHC I) so 
that it was captured by the Cytotoxic T Leucocyte 
receptor, CTL. The resulting cytokine IL2 induces 
CTL T cells to produce IFNγ. This could be seen 
in group C which showed IFNγ production was 
higher than group B and D.
IFNγ production could be conducted in 3 ways. 
First, T. gondii infection in macrophages stimulates 
macrophages producing IL12, TNFα, IL1, and IL15. 
IL12 cytokines with IL1β, IL15, and TNFα, stimu-
late NK cells to produce IFNγ. The cytokine IFNγ 
then activates the TNFα macrophages. IFNγ syner-
gizes with TNFα induces the expression of intracel-
lular nitric oxide synthase (iNOS), which produces 
nitric oxide (NO) to kill intracellular T. gondii.27 
Second, T. gondii infection in macrophages or APC 
encourages to produce IL12. APC presents a para-
sitic peptide through MHC II, so it is recognized 
by Th cells (CD4+ T cells). The Th cells binding 
to MHC II produce IL2. IL2 cytokines of Th and 
IL12 cells of APC induce differentiation from Th 
into Th1. Th1 cells produce IFNγ.26 Third, infected 
macrophages or APCs T. gondii express MHC I 
recognized by CTL T cells. CTL T cell bonds with 
APC via MHC I and the presence of IL2 produced 
Th cells trigger CTL T cells resulting IFNγ.27
Rats infected with T.gondii showed an increase in 
the number of femur bone cells expressing TNFα. 
Previous studies of T. gondii infection increased the 
number of placental decidual macrophages,26 muscle 
cells,28 liver and lymph cells29 expressing TNFα. 
Increased TNFα in T. gondii infection is a cascade of 
the body’s immune response to eliminate parasites. In 
this experiments showed that there was an increase of 
TNFα concentration in serum especially in group A 
and group C, and it showed that TNFα was important 
Figure 1 Mean of IFNγ between group
Figure 2 Mean of TNFα between group
Figure 3 Comparison between IFNγ and TNFα
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for immune response to eliminate T.gondii. This was 
consistent with the results of this study which showed 
that TNFα concentrations in group A and group C 
also increased with IFNγ increment and this function 
was used to eliminate T. gondii whereas in uninfected 
groups B and D had high TNFα concentrations. It 
could be stated that the administration of OHB in this 
study might increase the concentration of IFNγ and 
TNFα in serum to eliminate T. gondii.
Suwanti (2005) suggest that TNFα increased in 
conjunction with increased IFNγ in the placenta 
induce trophoblasts expressing Fas and stimulating 
Fas more sensitive to apoptosis.26 This can cause the 
implantation process to run smoothly, whereas if 
apoptosis occurs excessively it will cause abortion. 
Rats in group A were infected and given HBOT, 
have high IFNγ and TNFα levels did not cause 
abortion in rats although we can see that very high 
Table 1 Test of Homogeneity of Variances
(I) Group 
TNFα
(J) Group 
TNFα
Mean Difference 
(I-J) Std. Error Sig.
95% Confidence Interval
Lower Bound Upper Bound
A B 45.23200* 15.74722 0.007 13.0719 77.3921
C -10.68913 16.29993 0.517 -43.9780 22.5998
D 36.26342* 14.63422 0.019 6.3764 66.1505
B A -45.23200* 15.74722 0.007 -77.3921 -13.0719
C -55.92113* 16.29993 0.002 -89.2100 -22.6322
D -8.96858 14.63422 0.545 -38.8556 20.9185
C A 10.68913 16.29993 0.517 -22.5998 43.9780
B 55.92113* 16.29993 0.002 22.6322 89.2100
D 46.95255* 15.22737 0.004 15.8541 78.0510
D A -36.26342* 14.63422 0.019 -66.1505 -6.3764
B 8.96858 14.63422 0.545 -20.9185 38.8556
C -46.95255* 15.22737 0.004 -78.0510 -15.8541
Table 2 Multiple comparison IFNγ
(I) Group 
IFNγ
(J) Group 
IFNγ
Mean Difference 
(I-J) Std. Error Sig.
95% Confidence Interval
Lower Bound Upper Bound
A B 16.352250* 3.552591 0.000 9.09689 23.60761
C 4.384125 3.677281 0.243 -3.12589 11.89414
D 10.625761* 3.301495 0.003 3.88321 17.36831
B A -16.352250* 3.552591 0.000 -23.60761 -9.09689
C -11.968125* 3.677281 0.003 -19.47814 -4.45811
D -5.726489 3.301495 0.093 -12.46904 1.01606
C A -4.384125 3.677281 0.243 -11.89414 3.12589
B 11.968125* 3.677281 0.003 4.45811 19.47814
D 6.241636 3.435311 0.079 -.77421 13.25748
D A -10.625761* 3.301495 0.003 -17.36831 -3.88321
B 5.726489 3.301495 0.093 -1.01606 12.46904
C -6.241636 3.435311 0.079 -13.25748 .77421
*. The mean difference is significant at the 0.05 level.
Table 4 ANOVA between and within group
Sum of Squares Df Mean Square F Sig.
Between Groups 1236.242 3 412.081 8.163 0.000
Within Groups 1514.508 30 50.484
Total 2750.751 33
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IFNγ and TNFα concentrations were compared 
with groups B and D. Inverted results were shown 
by group B which had IFNγ and TNFα concentra-
tions are lower than group B.
The leukocyte population in the decidua is 
dominated by macrophages, NK cells, and CTL T 
cells, as well as Th cells. So if there is an infection 
in the decidua, the lymphocytes in the decidua are 
activated to produce IFNγ.26 This is consistent with 
the results of this study which showed high IFNγ 
results in the group infected with tachyzoite in 
group C, especially the higher increase in group A 
given HBOT.
Plasmodium falciparum infection could increase 
the levels of IFNγ and IL-2 in the placenta. IFNγ 
and TNFα were associated with poor pregnancy 
outcomes in the form of fetal loss and weight of 
infants born small.30 P. falciparum parasites are 
protozoa belonging to one ordo with T. gondii. 
Different results were shown by this study where 
increases in IFNγ and TNFα did not show an abor-
tion during the study.
HBOT administration in this study not only 
works by increasing the amount of oxygen in the 
tissue but also produces H2O2 which can become 
a second messenger to activate NF-kB which ulti-
mately can increase the activity of inflammatory 
responses such as TNFα and IFNγ. IFNγ gave 
protection against Toxoplasma gondii infection 
through STATI molecules in the JAK / STAT 
pathway.31,32 IFNγ would induce INDO formation 
which then will degrade tryptophan in non-phago-
cytic cells and induce increased secretion of reactive 
oxygen intermediate (ROI), nitric oxide (NO) and 
reactive nitrogen intermediate (RNI) in phagocytic 
cells. Tryptophan degradation inhibits replication 
tachyzoite of T. gondii.31 IFNγ also induced synthe-
sis of IGTP and LRG-47 which could control the 
development of splenocytes.32
Tc / CD8 + cells activate NK cells and macro-
phages by producing a toxic ROI, NO or RNI for 
tachyzoites through IFNγ production.10 The authors 
suggest that a high concentration of IFNγ in group 
A and C help the immune system to eliminate 
tachyzoite of T.gondii. The sequence of cytokines 
capable of causing tissue and organ damage when 
secreted in high quantities is IL-18, IFNγ, IL12 and 
TNFα.33 So if the concentration of IFNγ and TNFα 
is very high and not in optimum concentration 
(group A, B, C, and D), abortion will happen. But 
in this case, the authors found that HBOT could 
increase IFNγ and TNFα concentrations without 
causing abortion. In this case, serum TNFα levels 
in group A were higher than in group C. This was 
in contrast to previous studies in foot ulcer patients 
with diabetes showing a decrease in TNFα levels 
in patients after HBOT administration.34 In the 
study of giving HBOT therapy to other wounds 
also showed a reduction in inflammation with a 
decrease in TNFα, IL10, MMP9, and IL8.
The figure 3 showed that TNFα always followed 
the increase in IFNγ value but the rise of IFNγ 
and TNFα values in the four groups had different 
values, and it might have different implications for 
the elimination and protection of different powers 
possessed by Rattus novergicus against Toxoplasma 
gondii infection. There was an effect of giving 
HBOT to TNFα levels in pregnant Rattus nover-
gicus infected with T. gondii which was significant 
between group A and group B (p = 0.007), group A 
with group D (p = 0.019), and group B with group C 
(p = 0.002). Even though it was obtained a p-value 
= 0.545 between group A and group C, it tended 
to be insignificant. It was found that the increase 
in the number of TNF α in group A compared to 
group C was quite significant with the improve-
ment of clinical conditions of the rats.
As from the results of statistical tests, it was 
found there was an effect of giving HBOT to IFNγ 
levels in pregnant Rattus novergicus infected with T. 
gondii which was significant between group A with 
group B (p = 0.000), group A with group D (p = 
0.003), and group B with group C (p = 0.003). It 
obtained p = 0.243 between group A and group C 
or it tended to be insignificant. It was found that 
the increase in the number of IFN group in group 
A compared to group C was quite significant with 
the improvement of clinical conditions of the rats 
and the most important was that the rats had no 
experience of abortion.
IFNγ and TNFα data were carried out by Pearson 
statistical test, and the results showed that p-value 
<0.041 which means there was a correlation between 
IFNγ and TNFα levels. Increased levels of IFNγ 
will be followed by TNFα to eliminate Toxoplasma 
gondii in the body of rats. Previous research stated 
that IFNγ and TNFα both singly and jointly inhib-
ited multiplication and activate macrophage cells to 
eradicate tachyzoite and to prevent reactivation of 
bradyzoites.2,10,31,35,36 According to Ceravolo et  al. 
(1999), TNFα can impede tachyzoite multiplication 
up to 30%. The IFNγ could impede tachyzoite repli-
cation by 54% to 65%. Besides, the combination of 
IFNγ with TNFα could inhibit tachyzoite replica-
tion by 73%.31 IFNγ also plays a role in the induc-
tion of switching from IgM to IgG2a which is very 
important for the immune response to toxoplasmo-
sis.22 So the administration of HBOT might provide 
a good influence for elimination and protection of 
Toxoplasma gondii in pregnant Rattus novergicus.
Based on ANOVA test, there was a significant 
correlation between hyperbaric oxygen therapy at 
IFNγ and TNFα concentrations in pregnant rats 
infected with T. gondii tachyzoite (between groups A, 
99Published by DiscoverSys | Bali Med J 2019; 8(1): 94-100 | doi: 10.15562/bmj.v8i1.1316
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B, C, D and within the group). So, the administration 
of HBOT could have a significant effect on tachyzoite 
infection in pregnant rats as indicated by p <0.000. 
During the study, there were no rats that experi-
enced abortion or died while undergoing treatment, 
besides the results of intra-peritoneal fluid smears of 
rats group A and C (rats pregnant and infected with 
tachyzoite) were not found tachyzoite. Based on the 
results of this study, HBOT could improve the expres-
sions of IFNγ and TNFα, in the provision of HBOT 
2.4 ATA for 3x30 minutes with ten sessions in 5 days.
CONCLUSION
HBOT can improve the expressions of IFNγ and 
TNFα, in the provision of HBOT 2.4 ATA for 3x30 
minutes, ten times in 5 days and HBOT administra-
tion can prevent abortion in pregnant rats infected 
with tachyzoite T. gondii.
ACKNOWLEDGMENTS 
Thanks to the study group of Toxoplasma gondii 
Faculty of Veterinary Medicine of Airlangga 
University who are willing to provide Tachyzoite 
sample for this research. Thank you also to the 
Department of Hyperbaric Faculty of Medicine 
Hang Tuah University Surabaya on permission 
to use Hyperbaric Chamber. Thanks to Bupati of 
Sidoarjo and Head of Public Health Office Sidoarjo 
for permission to study.
DISCLOSURE
The author reports no conflicts of interest in this 
work.
REFERENCES 
1. Al-Fertosi, Raghed B. and Juma, Ameena S.M. 2006. 
Possible Cellular Expression of IFNγ in woman with 
abortion infected Toxoplasma gondii. Medical Journal of 
Islamic World Academy of Sciences 16:3, 121-134
2. Darcy F, Santoro S. 1994. Toxoplasmosis. In: Parasitic 
infections and the immune system. Ed by F Kierszenbaum. 
Academic Press, Inc, San Diego, Calif, pp 163-201.
3. Kahn IA, Matsuura T, Kasper LH. 1994. Interleukin-12 
enhances survival against acute toxoplasmosis. Infect 
Immun, 62:1639-1642.
4. Hunter CA, Chizzonite R, Remington JS. 1995. 1L-1 beta 
is required for 1L-12 to induce production of IFN-γ by 
NK cells: a role for 1L-1 beta in the T cell-independent 
mechanism of resistance against intracellular pathogens. J 
Immunol, 155:4347-4354.
5. Shirahata T, Muroyo N, Ohta C, Goto H, Nakane A. 1992. 
Correlation between increased susceptibility to primary 
T. gondii infection and depressed production of gamma 
interferon in pregnant rats. Microbiol Immunol, 36:81-91.
6. Marshall AJ, Denkers EY. 1998. Toxoplasma gondii trig-
gers granulocyte-dependent cytokine-mediated lethal 
shock in D galactosamine sensitized rats. Infect Immun, 
66:1325-1333.
7. Roberts CW, Walkker W, Alexander J. 2001. Sex medi-
ate hormones and immunity to protozoan parasite. Clin 
Microbiol, 14:476-488.
8. Lin H, Mosmann TR, Gulibert L, Tuntipopipat S, 
Wegmann TG. 1993. Synthesis of T helper 2- type cytokines 
at the maternal-fetal interface. J Immunol, 151:4562-4573.
9. Jenkins C, Roberts J, Wilson R, Maclean MA, Shilito T, 
Walker JJ. Evidence of TH1 type response associated with 
recurrent miscarriage. Fer Ster, 2000; 73:1206-1208.
10. Denkers, E.Y . and R.T. Gazzinelli. Regulation and func-
tion of T-cell-mediated immunity during Toxoplasma 
gondii infection. CM. Microbiol. Rev. 1998; 11: 569 - 588.
11. Sher, A., E.Y. Denkers, and R.T. Gazzinelli. Induction and 
regulation of host cell-mediated immunity by Toxoplasma 
gondii. Ciba Found. Symp. 1995; 195:95-109.
12. Vlodavsky E, Palzur E, Soustiel JF. Hyperbaric oxygen 
therapy reduces neuroinflammation and expression of 
matrix metalloproteinase-9 in the rat model of traumatic 
brain injury. Neuropathol Appl Neurobiol. 2006; 32:40-50.
13. Lin KC, Niu KC, Tsai KJ, Kuo JR, Wang LC, Chio CC, 
Chang CP. Attenuating inflammation but stimulating both 
angiogenesis and neurogenesis using hyperbaric oxygen in 
rats with traumatic brain injury. J Trauma Acute Care Surg 
2012; 72:650-659
14. Zhang Y, Yang Y, Tang H, Sun W, Xiong X, Smerin D, 
Liu J. Hyperbaric oxygen therapy ameliorates local brain 
metabolism, brain edema and inflammatory response in 
a blast-induced traumatic brain injury model in rabbits. 
Neurochem Res. 2014; 39:950-960.
15. Meng XE, Zhang Y, Li N, Fan DF, Yang C, Li H, Guo DZ, 
Pan SY. Effects of hyperbaric oxygen on the Nrf2 signal-
ing pathway in secondary injury following traumatic brain 
injury. Genet Mol Res; 2016a. doi:10.4238/gmr.15016933. 
16. Kalns J, Lane J, Delgado A, Scruggs J, Ayala E, Gutierrez E, 
Warren D, Niemeyer D, George Wolf E, Bowden RA. 
Hyperbaric oxygen exposure temporarily reduces Mac-1 
mediated functions of human neutrophils. Immunol Lett. 
2002; 83:125-131.
17. Chen X, Duan XS, Xu LJ, Zhao JJ, She ZF, Chen WW, 
Zheng ZJ, Jiang GD. Interleukin-10 mediates the neuro-
protection of hyperbaric oxygen therapy against traumatic 
brain injury in rats. Neuroscience 2014; 266:235-243.
18. Lim SW, Wang CC, Wang YH, Chio CC, Niu KC, Kuo JR. 
Microglial activation induced by traumatic brain injury is 
suppressed by postinjury treatment with hyperbaric oxy-
gen therapy. J Surg Res. 2013; 184:1076-1084.
19. Meng XE, Zhang Y, Li N, Fan DF, Yang C, Li H, Guo DZ, 
Pan SY. Hyperbaric oxygen alleviates secondary brain 
injury after trauma through inhibition of TLR4/
NF-kappaB signaling pathway. Med Sci Monit. 2016b; 
22:284-288.
20. Abou-Bacar, A., A.W. Pfaff, S. George, V. Letscherbru, D. 
Filisetti, O. Villard, E . Antoni, J-P. Klein and E. Candolfi. 
Role of NK cells and gamma interfere in transplacental 
passage of Toxoplasma gondii in mouse model of primary 
infection. Infect. Immun. 2004a; 72: 1397 - 1401.
21. Pfaff, A.W., S. Georges, A. Abou-Bacar, V. Letscherbru, J-P. 
Klein, M. Mousli and E . Candolfi. Toxoplasma gondii reg-
ulates IC AM-1 mediated monocyte adhesion to tropho-
blasts. Immunol. Cell. Biol; 2005 (In Press)
22. Abbas, A.K ., A.H. Lichtman and J .S. Pober. 2000. Cellular 
and Molecular Immunology. W.B. Saunders Company, 
Philadelphia; 235- 338.
23. Channon, J .Y ., R.M. Seguin and L.H. Kasper. Differential 
infectivity and division of Toxoplasma gondii in human 
peripheral blood leukocytes. Infect. Immun. 2000; 68: 
4822 – 4826. 
24. Barragan, A. and L.D. Sibley. Transepithelial migration of 
Toxoplasma gondii is linked to parasite motility and viru-
lence. J . Exp. Med. 2002; 195: 1625 -1633 .
25. Abou-Bacar, A., A.W. Pfaff, V. Letscherbru, D. Filisetti, R. 
Rajapakse. E. Antoni, O. Villard, J-P. Klein and E . 
Candolfi. Role of gamma interferon and T cells in congeni-
tal toxoplasma transmission. Parasite Immunol. 2004b; 26: 
315 - 318.
100 Published by DiscoverSys | Bali Med J 2019; 8(1): 94-100 | doi: 10.15562/bmj.v8i1.1316
ORIGINAL ARTICLE
26. Suwanti, L.T. Mechanism of Increasing Trophoblast 
Apoptosis in Rats Infected with Toxoplasma gondii 
through Increased Decidual cell of IFNγ and TNFα-
producing and Trophoblast Producing FAS and TNFR-1. 
Dissertation. Graduate program at Airlangga University. 
Surabaya; 2005.
27. Suwanti. et  al. Respons Imun Seluler Plasenta t erha-
dap Infeksi Toxoplasma gondii pada Berbagai Umur 
Kebuntingan Mencit (Mus musculus); 2006: 22(3): 168–
173. Taken from journal.unair.ac.id/download-fullpa-
pers-MKH-22-3-30.pdf
28. Mufasirin. Mekanisme Berat Lahir Rendah Anak Mencit 
dari Induk Toksoplasmosis Melalui Perubahan Molekuler 
Sel Otot Skelet. Disertasi. Program Pascasarjana 
Universitas Airlangga. Surabaya; 2011.
29. Mordue, D.G., F. Monroy, M.L. Regina, C.A. Dinarello, 
and L.D. Sibley. Acute toxoplasmosis leads to lethal 
overproduction of Th1 cytokines. J. Immunol. 2001; 
167:4574-4584. 
30. Fried M, Nosten F, Brockman A, Brabin BJ, 
Duffy  PE. Maternal antibodies block malaria.  Nature. 
1998; 395:851–852
31. Ceravolo, I .P., A.C .L . Chaves, C .A. Bonjardim, D . 
Sibley, A.J . Romanha and R.T . Gazzinelli. Replication of 
Toxoplasma gondii, but not Trypanozoma cruzi, is regu-
lated in human fibroblast activated with gamma inter-
ferons: Requirement of functional JAK/STAT pathway . 
Infect. Immun. 1999; 67:2233 -2340.
32. Gavrilescu, L.C ., B.A. Butcher, L .D . Rio, G .A. Taylor and 
E .Y. Denkers. STAT 1 is essential for antimicrobial effector 
function but dispensable for gamma interferon production 
during Toxoplasma gondii infection. Infect. Immun. 2004; 
72: 1257 - 1264.
33. Sibley, L.D., D.G. Mordue, C. Su, P.M. Robben, and D.K. 
Howe. Genetic approaches to studying virulence and 
pathogenesis in Toxoplasma gondii. Phil. Trans. R. Soc. 
Lond B. 2002; 357: 81 - 88.
34. Semadi, I Nyoman. Efek Terapi Adjuvan Oksigen 
Hiperbarik Terhadap Penyembuhan Ulkus Kaki Diabetik 
Wagner 3-4 Penderita Diabetes Mellitus Tipe-2 Dengan 
Penanda CD34, VEGF dan TNFα. Disertasi. Program 
Pendidikan Doktor Fakultas Kedokteran Universitas 
Udayana Bali; 2017.
35. Gazzinelli, R.T ., A. Brezin, Q. Lt ., R .B. Nussenblatt and C. 
Chan. Toxoplasma gondii: Acquired ocular toxoplasmo-
sis in the marine model, the protective role of TNF-a and 
IFN-y. Exp. Parasitol. 1994; 78: 217 - 229.
36. Vercammen, M., T. Scoria, K. Huygen, J. De Braekeleer, R. 
Diet, D. Jacobs, E. Saman and H . Verschueren. DNA vac-
cination with genes encoding Toxoplasma gondii antigens 
GRAI, GRA7, and ROP2 induces partially protective 
immunity against lethal challenge in rats. Infect. Immun. 
2000; 68: 38-45 .
This work is licensed under a Creative Commons Attribution
